Smith & Nephew restructuring provides potential $750 million war chest
This article was originally published in Clinica
Executive Summary
Smith & Nephew, the UK orthopaedics, wound management and endoscopy company, could have as much as £500 million ($750 million) to spend on acquiring new businesses. The company's CEO Chris O'Donnell said that financial restructuring has given S&N a borrowing power that will enable it to add companies at the rate of two or three a year.